• ERCC1 Deficiency, p53, and Platinum Response in Lung Cancer

  2026-08-26

  Heyza and colleagues used CRISPR-Cas9-engineered lung cancer models to show that ERCC1 deficiency does not predict cisplatin response independently of p53 status. Their findings identify p53-dependent apoptosis, altered interstrand crosslink repair kinetics, and DNA-PKcs/BRCA1 activity as important variables when interpreting ERCC1 as a platinum-response biomarker.

• Phytol Workflows for RXR Signaling and Assays

  2026-08-25

  Build more informative Phytol experiments by combining solvent-aware dosing, RXR transcriptional readouts, and orthogonal checks for metabolism and GABAergic effects. A polymer self-assembly study adds a useful design lesson: systematically map composition, architecture, and time rather than assuming one condition predicts the whole response.

• Spatial Proteomics of Therapeutic-Releasing Brain Probes

  2026-08-25

  This 2026 Journal of Materials Chemistry B study develops a titania nanotube array coating that combines antimicrobial activity with localized therapeutic release on intracortical microelectrodes. Spatial proteomics identified how neuronal integrity, immune activation, and cytokine-associated responses vary around the probe, providing design guidance for side-specific coatings and future chronic neural interfaces.

• PDHA1 Succinylation, α-KGA, and Immune Escape

  2026-08-24

  A 2025 Nature Communications study identifies PDHA1 lysine 83 succinylation as a metabolic control point in cholangiocarcinoma. The modification increases α-ketoglutaric acid accumulation, activates macrophage OXGR1–MAPK signaling, suppresses MHC-II antigen presentation, and may contribute to chemotherapy resistance.

• CKI 7 Dihydrochloride: CK1 Assay Workflows

  2026-08-24

  Build more interpretable Wnt, circadian, apoptosis, and cancer-cell assays with CKI 7 dihydrochloride, a practical Casein kinase 1 inhibitor for controlled pathway perturbation. The workflow also shows how to place CK1 experiments beside, rather than mistakenly substitute them for, the MAPK10–KRT16 metastasis mechanism reported in NSCLC.

• WY-14643: PPARα Workflows for Liver Research

  2026-08-23

  WY-14643 (Pirinixic Acid) is a selective PPARα tool for connecting lipid metabolism regulation with inflammation, insulin sensitivity enhancement, and liver growth biology. This practical guide separates literature-backed dosing from pilot recommendations and shows how to combine metabolic, endothelial, histological, and YAP-TEAD readouts.

• CD38 CAR Binder Structure and Affinity Tuning

  2026-08-22

  This iScience study defines how two CD38-targeting CAR binders engage distinct antigen surfaces and couple binding geometry to enzymatic inhibition, fratricide, and tumor-cell killing. Its structure-guided analysis supports a more nuanced approach to CAR optimization in which affinity, epitope, catalytic modulation, and cellular selectivity are tuned together rather than treated as independent variables.

• SMPD4, Ceramide, and Primary Cilia in Brain Development

  2026-08-22

  The 2024 Development study identifies SMPD4-dependent ceramide production as a mechanistic link between sphingolipid metabolism, primary-cilium formation, neural progenitor survival, and brain development. By combining a mouse model with SMPD4-deficient human induced pluripotent stem cells and a ceramide-rescue experiment, the work clarifies how SMPD4 variants may cause microcephaly and cerebellar hypoplasia.

• NF90, AGEs, and Diabetic Atherosclerotic Calcification

  2026-08-21

  This Nature Communications study identifies smooth muscle NF90/110 as a mechanistic link between advanced glycation end products and diabetic atherosclerotic calcification. Using male mouse models, vascular smooth muscle cell experiments, and human calcified samples, the authors define an NF90–FBXW7–AGER1 axis that may be useful for studying calcification, apoptosis, and AGE handling in diabetic vascular disease.

• Neurotensin Workflows for GPCR Trafficking

  2026-08-20

  Build time-resolved assays around Neurotensin as a Neurotensin receptor 1 activator to connect receptor recycling with miR-133α modulation. This practical guide combines peptide handling, trafficking and miRNA readouts, plus cautious fluorescence-processing strategies adapted from a recent spectral-classification study.

• Trelagliptin, PI3K/AKT, and Adipocyte Insulin Resistance

  2026-08-20

  The reference study links trelagliptin succinate exposure with improved insulin signaling, GLUT4 translocation, and glucose uptake in differentiated 3T3-L1 adipocytes. Its innovation is the integration of phosphorylation-related signaling measurements with adipokine and free-fatty-acid readouts, while the in vitro model limits direct clinical and causal interpretation.

• CD44, Copper, and Ly6Chi Macrophages in Colitis

  2026-08-19

  The reference study identifies a mechanistic connection between CD44 upregulation, intracellular copper accumulation, and activation of inflammatory Ly6Chi macrophages in ulcerative colitis. Its combination of single-cell analysis, pharmacological intervention, proteomics, and macrophage experiments suggests that copper handling and oxidative stress are important links between macrophage state and intestinal inflammation.

• EZ Cap™ EGFP mRNA (5-moUTP) for Assays

  2026-08-19

  This scenario-driven guide explains how EZ Cap™ EGFP mRNA (5-moUTP), SKU R1016, can improve interpretation of viability, proliferation, cytotoxicity, and delivery experiments. It links transcript design, handling, controls, and vendor selection to practical laboratory decisions.

• Tunicamycin B7417 for Reliable ER-Stress Assays

  2026-08-18

  A scenario-based guide to using Tunicamycin (SKU B7417) as a N-glycosylation inhibitor in cell viability, proliferation, cytotoxicity, and macrophage inflammation workflows. It explains mechanism, protocol controls, interpretation of GRP78, COX-2, and iNOS data, and practical criteria for selecting a reliable research reagent.

• Deep Learning for iPSC-CM Cardiotoxicity Screening

  2026-08-18

  Grafton and colleagues developed a high-content screening workflow that combines induced pluripotent stem cell-derived cardiomyocytes with deep-learning image analysis to identify cardiotoxic phenotypes. The study shows how a single phenotypic score can prioritize liabilities across mechanistically diverse compounds and support earlier safety decisions in drug discovery.

454 records 1/31 page Next 12345 下5页 Last page